Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis

被引：0
|
作者：
A. J. Feuerherm
E. A. Dennis
B. Johansen
机构：
[1] Norwegian University of Science and Technology,Department of Biology
[2] University of California−San Diego,Department of Chemistry and Biochemistry
[3] University of California−San Diego,Department of Pharmacology, School of Medicine
来源：
Arthritis Research & Therapy | / 21卷
关键词：
cPLA2α; Disease-modifying; Anti-rheumatic; Small molecule inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 15 条
  • [1] Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis
    Feuerherm, A. J.
    Dennis, E. A.
    Johansen, B.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [2] The ω3-polyunsaturated fatty acid derivatives AVX001 and AVX002 directly inhibit cytosolic phospholipase A2 and suppress PGE2 formation in mesangial cells
    Huwiler, Andrea
    Feuerherm, Astrid J.
    Sakem, Benjamin
    Pastukhov, Oleksandr
    Filipenko, Iuliia
    Thuy Nguyen
    Johansen, Berit
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (08) : 1691 - 1701
  • [3] The role of cytosolic phospholipase A2 in collagen-induced arthritis
    Berger, Slava
    Raichel, L.
    Levy, R.
    INFLAMMATION RESEARCH, 2007, 56 : S423 - S423
  • [4] Cytosolic phospholipase A2α-deficient mice are resistant to collagen-induced arthritis
    Hegen, M
    Sun, LH
    Uozumi, N
    Kume, K
    Goad, ME
    Nickerson-Nutter, CL
    Shimizu, T
    Clark, JD
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (10): : 1297 - 1302
  • [5] 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity
    Antonopoulou, Georgia
    Magrioti, Victoria
    Kokotou, Maroula G.
    Nikolaou, Aikaterini
    Barbayianni, Efrosini
    Mouchlis, Varnavas D.
    Dennis, Edward A.
    Kokotos, George
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (19) : 4544 - 4554
  • [6] 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
    Kokotou, Maroula G.
    Galiatsatou, Gerasimia
    Magrioti, Victoria
    Koutoulogenis, Giorgos
    Barbayianni, Efrosini
    Limnios, Dimitris
    Mouchlis, Varnavas D.
    Satpathy, Banita
    Navratil, Aaron
    Dennis, Edward A.
    Kokotos, George
    SCIENTIFIC REPORTS, 2017, 7
  • [7] 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
    Maroula G. Kokotou
    Gerasimia Galiatsatou
    Victoria Magrioti
    Giorgos Koutoulogenis
    Efrosini Barbayianni
    Dimitris Limnios
    Varnavas D. Mouchlis
    Banita Satpathy
    Aaron Navratil
    Edward A. Dennis
    George Kokotos
    Scientific Reports, 7
  • [8] A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis
    Omland, S. H.
    Habicht, A.
    Damsbo, P.
    Wilms, J.
    Johansen, B.
    Gniadecki, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : 1161 - 1167
  • [9] Binding Conformation of 2-Oxoamide Inhibitors to Group IVA Cytosolic Phospholipase A2 Determined by Molecular Docking Combined with Molecular Dynamics
    Mouchlis, Varnavas D.
    Michopoulou, Vasiliki
    Constantinou-Kokotou, Violetta
    Mavromoustakos, Thomas
    Dennis, Edward A.
    Kokotos, George
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (01) : 243 - 254
  • [10] Cytosolic Phospholipase A2α Gene Silencing in the Myeloid Lineage Alters Development of Th1 Responses and Reduces Disease Severity in Collagen-Induced Arthritis
    Courties, G.
    Baron, M.
    Presumey, J.
    Escriou, V.
    van Lent, P.
    Scherman, D.
    Cantagrel, A.
    van den Berg, W. B.
    Jorgensen, C.
    Apparailly, F.
    Davignon, J. -L.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (03): : 681 - 690
12